Increasing use of single and combination medical therapy in patients hospitalized for acute myocardial infarction in the 21st century: A multinational perspective

Archives of Internal Medicine

Volumn 167, Issue 16, 2007, Pages 1766-1773

  Goldberg, Robert J ^a,b   Spencer, Frederick A ^c   Steg, Philippe Gabriel ^d   Flather, Marcus ^e   Montalescot, Gilles ^f   Gurfinkel, Enrique P ^g   Kennelly, Brian M ^h   Goodman, Shaun G ^i,j   Dedrick, Rebecca ^b   Gore, Joel M ^b  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c MCMASTER UNIVERSITY   (Canada)

^d BICHAT HOSPITAL   (France)

^e ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

^h HOAG MEMORIAL HOSPITAL PRESBYTERIAN   (United States)

ⁱ CANADIAN HEART RESEARCH CENTRE   (Canada)

^j ST MICHAEL'S HOSPITAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; CARDIOGENIC SHOCK; DIABETES MELLITUS; DRUG USE; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HOSPITAL PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; ST SEGMENT ELEVATION; STROKE;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTILIPEMIC AGENTS; DRUG INFORMATION SERVICES; DRUG UTILIZATION REVIEW; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INPATIENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PRESCRIPTIONS, DRUG; RETROSPECTIVE STUDIES; WORLD HEALTH;

EID: 34548629357     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.167.16.1766     Document Type: Review

References (22)

1. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practicing Guidelines. J Am Coll Cardiol. 2002;40(7):1366-1374.
2. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; Canadian Cardiovascular Society. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation. 2004;110(9):e82-e292.
3. GRACE Investigators. Rationale and design of the GRACE (Global Registry for Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J. 2001;141(2):190-199.
4. Eagle KA, Goodman SG, Avenum A, et al. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet. 2002;359(9304):373-377.
5. Steg PG, Goldberg RJ, Gore JM, et al. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol. 2002;90(4):358-363.
6. Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 1999;34(3):890-911.
7. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G; Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. N Engl J Med. 2000;342(3):145-153.
8. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet. 2002;360(9326):7-22.
9. Fitchett DH, Borgundvaag B, Cantor W, et al. Non-ST segment elevation acute coronary syndromes: a simplified risk-oriented algorithm. Can J Cardiol. 2006;22(8):663-677.
10. Spencer F, Scleparis G, Goldberg RJ, et al. Decade-long trends (1986 to1997) in the medical management of patients with acute myocardial infarction: a community-wide perspective. Am Heart J. 2001;142(4):594-603.
11. Spencer FA, Lessard D, Yarzebski J, et al. Decade-long changes in the use of combination evidence-based medical therapy at discharge for patients surviving acute myocardial infarction. Am Heart J. 2005;150(4):838-844.
12. Perschbacher JM, Reeder GS, Jacobsen SJ, et al. Evidence-based therapies for myocardial infarction: secular trends and determinants of practice in the community. Mayo Clin Proc. 2004;79(8):983-991.
13. Rogers WJ, Canto JG, Lambrew CT, et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol. 2000;36(7):2056-2063.
14. Goldberg RJ, Gurwitz JH. Disseminating the results of clinical trials to community-based practitioners: is anyone listening? Am Heart J. 1999;137(1):4-7.
15. Stafford RS, Radley DC. The underutilization of cardiac medications of proven benefit, 1990 to 2002. J Am Coll Cardiol. 2003;41(1):56-61.
16. Abdallah MH, Arnaout S, Karrowni W, Dakik HA. The management of acute myocardial infarction in developing countries. Int J Cardiol. 2006;111(2):189-194.
17. Krumholz HM, Radford MJ, Wang Y, et al. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA. 1998;280(7):623-629.
18. Rathore SS, Mehta RH, Wang Y, et al. Effects of age on the quality of care provided to older patients with acute myocardial infarction. Am J Med. 2003;114(4):307-315.
19. McLaughlin TJ, Soumerai SB, Willison DJ, et al. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for under-treatment in women and the elderly. Arch Intern Med. 1996;156(7):799-805.
20. Clarke KW, Gray D, Keating NA, et al. Do women with acute myocardial infarction receive the same treatment as men? BMJ. 1994;309(6954):563- 566.
21. Mehta RH, Montoye CK, Gallogly M, et al. Improving quality of care for acute myocardial infarction: the Guidelines Applied in Practice (GAP) Initiative. JAMA. 2002;287(10):1269-1276.
22. Hoekstra JW, Pollack CV Jr, Roe MT, et al. Improving the care of patients with non-ST-elevation acute coronary syndromes in the emergency department: the CRUSADE initiative. Acad Emerg Med. 2002;9(11):1146-1155.